Hypertensive disease
|
0.200 |
GeneticVariation
|
group |
BEFREE |
Hypertension-causing cullin 3 mutations disrupt COP9 signalosome binding.
|
31813255 |
2020 |
Hypertensive disease
|
0.200 |
GeneticVariation
|
group |
BEFREE |
The renal effects of CNIs mimic the hypertension and hyperkalemia that result from germ-line mutations in with-no-lysine (WNK) kinases and the Kelch-like 3 (KLHL3)-CUL3 ubiquitin ligase complex.
|
30718414 |
2019 |
Hypertensive disease
|
0.200 |
GeneticVariation
|
group |
BEFREE |
CUL3 mutations cause severe vascular dysfunction, arterial stiffness and hypertension due to defects in vascular smooth muscle.
|
31184598 |
2019 |
Hypertensive disease
|
0.200 |
GeneticVariation
|
group |
BEFREE |
Mutations in the with-no-lysine kinase 1 (WNK1), WNK4, Kelch-like 3 (KLHL3), and Cullin3 (CUL3) genes were identified as being responsible for hereditary hypertensive disease pseudohypoaldosteronism type II (PHAII).
|
28414128 |
2017 |
Hypertensive disease
|
0.200 |
GeneticVariation
|
group |
BEFREE |
These data indicate that selective expression of the <i>Cul3</i>Δ<i>9</i> mutation in vascular smooth muscle phenocopies the hypertension observed in <i>Cul3</i>Δ<i>9</i> human subjects and suggest that mutations in CUL3 cause human hypertension in part through a mechanism involving smooth muscle dysfunction initiated by a loss of CUL3-mediated degradation of RhoA.
|
27882355 |
2016 |
Hypertensive disease
|
0.200 |
GeneticVariation
|
group |
BEFREE |
It has been shown previously that mutations in Cullin3 (Cul3) causing deletion of 57 amino acids encoded by exon 9 (Cul3Δ9) cause hypertension.
|
26100637 |
2015 |
Hypertensive disease
|
0.200 |
GeneticVariation
|
group |
BEFREE |
We here discuss a novel pathogenic mechanism underlying the hereditary hypertensive disease pseudohypoaldosteronism type II (PHAII), caused by mutations in three different genes encoding for Cullin-3, Kelch-like protein 3 (KLHL3), and with-no-lysine kinases (WNKs).
|
24992566 |
2014 |
Hypertensive disease
|
0.200 |
Biomarker
|
group |
BEFREE |
Hyperkalemic hypertension-associated cullin 3 promotes WNK signaling by degrading KLHL3.
|
25250572 |
2014 |
Hypertensive disease
|
0.200 |
GeneticVariation
|
group |
BEFREE |
Recent studies have identified Gordon's hypertension syndrome patients with mutations in either CUL3 (Cullin-3) or the BTB protein KLHL3 (Kelch-like 3).
|
23387299 |
2013 |
Hypertensive disease
|
0.200 |
GeneticVariation
|
group |
BEFREE |
Mutations in KLHL3 have been identified in patients with inherited hypertension disorders, and several of the disease-associated mutations are located in the presumed Cul3 binding region.
|
23573258 |
2013 |
Hypertensive disease
|
0.200 |
GeneticVariation
|
group |
BEFREE |
Since chronic acidosis and hypertension associated with PHA-II can result in delayed growth and development in pediatric patients, genetic analysis to detect the CUL3 mutation and to enable intervention early in the disease course would be beneficial for infants with suspected PHA-II.
|
23689903 |
2013 |
Hypertensive disease
|
0.200 |
Biomarker
|
group |
BEFREE |
Mutations in kelch-like 3 and cullin 3 cause hypertension and electrolyte abnormalities.
|
22266938 |
2012 |
Hypertensive disease
|
0.200 |
Biomarker
|
group |
HPO |
|
|
|